✦ LIBER ✦

34 Pharmacokinetic and pharmacodynamic evaluation of valganciclovir in solid organ transplant patients

✍ Scribed by O. Manuel; N. Perrottet; J.-P. Venetz; L.A. Decosterd; T. Buclin; M. Pascual; P. Meylan

Book ID: 118616430
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 101 KB
Volume: 10
Category: Article
ISSN: 1201-9712
DOI: 10.1016/s1201-9712(06)80032-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

How pharmacokinetic and pharmacodynamic

How pharmacokinetic and pharmacodynamic drug monitoring can improve outcome in solid organ transplant recipients

✍ Jochen Klupp; David W. Holt; Teun van Gelder 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Clinical Pharmacokinetics and Pharmacody

Clinical Pharmacokinetics and Pharmacodynamics of Prednisolone and Prednisone in Solid Organ Transplantation

✍ Troels K. Bergmann, Katherine A. Barraclough, Katie J. Lee, Christine E. Staatz 📂 Article 📅 2012 🏛 Springer International Publishing AG 🌐 English ⚖ 598 KB

666 Valganciclovir Pharmacokinetics and

666 Valganciclovir Pharmacokinetics and Determination of Optimal Dosing after Solid Organ Transplantation in Infants and Young Children

✍ D.F. Villeneuve; Y. Law; S. Gantt; T. Nemeth 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Treatment of Cytomegalovirus Infection o

Treatment of Cytomegalovirus Infection or Disease in Solid Organ Transplant Recipients with Valganciclovir

✍ Jacques Fellay; Jean-Pierre Venetz; Manuel Pascual; John-David Aubert; Charles S 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB

Analysis of cytomegalovirus DNA polymera

Analysis of cytomegalovirus DNA polymerase (UL54) mutations in solid organ transplant patients receiving valganciclovir or ganciclovir prophylaxis

✍ Guy Boivin; Nathalie Goyette; Christian Gilbert; Emma Covington 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

## Abstract We previously reported the absence of CMV __UL97__ (kinase) gene resistance mutations up to 12 months post‐transplant following 100 days of valganciclovir prophylaxis, and a low incidence of resistance mutations following 100 days of oral ganciclovir prophylaxis in a prospective multice

Incidence and characterization of cytome

Incidence and characterization of cytomegalovirus resistance mutations among pediatric solid organ transplant patients who received valganciclovir prophylaxis

✍ Mélanie Martin; Nathalie Goyette; Jane Ives; Guy Boivin 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 136 KB